Literature DB >> 20925591

Synergistic effect of emodin in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus.

Young-Seob Lee1, Ok-Hwa Kang, Jang-Gi Choi, You-Chang Oh, Joon-Ho Keum, Sung-Bae Kim, Gil-Saeng Jeong, Youn-Chul Kim, Dong-Won Shin, Dong-Yeul Kwon.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a substantial contributor to morbidity and mortality. In search of a natural products capable of inhibiting this multidrug resistant bacteria, we have investigated the antimicrobial activity of emodin (EM) isolated from Rheum palmatum L. (Polygonaceae) against 17 different strains of the bacterium. New antimicrobial activity was found using the paper disc diffusion method, agar dilution as well as checkerboard method. Against the 17 strains, the disc diffusion test was in the range of 18-30 mm, and the minimum inhibitory concentrations (MICs) of EM were in the range of 1.5-25 μg/mL. From those results we performed the checkerboard test to determine the synergism of EM in combination with ampicillin (AM) or oxacillin (OX) against all strains. The combined activity of EM and two antimicrobial agents (AM, OX) against all strains resulted in a fractional inhibitory concentrations index (FICI) ranging from 0.37-0.5 and from 0.37-0.75, respectively. The effect of EM with AM and OX was found to be synergistic or partially synergistic. We found that EM reduced the MICs of AM and OX. EM and in combination with AM or OX could lead to the development of new combination antibiotics against MRSA infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20925591     DOI: 10.3109/13880201003770150

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  7 in total

1.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

2.  In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii.

Authors:  Yajun Zhang; Fengzhe Chen; Enhua Sun; Ruiping Ma; Chunmei Qu; Lixian Ma
Journal:  Exp Ther Med       Date:  2013-04-02       Impact factor: 2.447

3.  Emodin Isolated from Polygoni cuspidati Radix Inhibits TNF-α and IL-6 Release by Blockading NF-κB and MAP Kinase Pathways in Mast Cells Stimulated with PMA Plus A23187.

Authors:  Yue Lu; Yong-Tae Jeong; Xian Li; Mi Jin Kim; Pil-Hoon Park; Seung-Lark Hwang; Jong Keun Son; Hyeun Wook Chang
Journal:  Biomol Ther (Seoul)       Date:  2013-11       Impact factor: 4.634

Review 4.  Recent Progress in Traditional Chinese Medicines and Their Mechanism in the Treatment of Allergic Rhinitis.

Authors:  Dehong Mao; Zhongmei He; Linglong Li; Yuting Lei; Maodi Xiao; Huimin Zhang; Feng Zhang
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

Review 5.  Antibacterial Action of Curcumin against Staphylococcus aureus: A Brief Review.

Authors:  Sin-Yeang Teow; Kitson Liew; Syed A Ali; Alan Soo-Beng Khoo; Suat-Cheng Peh
Journal:  J Trop Med       Date:  2016-11-13

6.  Emodin inhibits the proliferation and migration of B16F10 cells and induces their apoptosis.

Authors:  Mingjie Yuan; Liang Chen; Wanchen Wang; Dengke Qin; Chuanlong Jia; Chi Liu; Heng Wang; Jingjing Zhu; Yu Guo; Yiqun Zhou; Ping Yang; Haiguang Zhao; Tianyi Liu; Bo Bi
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

7.  Experimental anti-tumor effect of emodin in suspension - in situ hydrogels formed with self-assembling peptide.

Authors:  Weipeng Wei; Jianhua Tang; Lei Hu; Yujie Feng; Hongfang Li; Chengchen Yin; Fushan Tang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.